Vofatamab, CAS 1312305-12-6

Product Description: Vofatamab (B-701) is an anti-FGFR3 monoclonal antibody (mAb). Vofatamab blocks activation of both the wildtype and genetically activated receptor. Vofatamab can be used in the research of metastatic urothelial carcinoma (mUC)[1].

Applications: Cancer-Kinase/protease

Formula: N/A

References: [1]Andrea Necchi, et al. Fierce-21: Phase II study of vofatmab (B-701), a selective inhibitor of FGFR3, as salvage therapy in metastatic urothelial carcinoma (mUC). Journal of Clinical Oncology 2019 37:7_suppl, 409-409.

CAS Number: 1312305-12-6

Molecular Weight: N/A

Compound Purity: 95.00

Research Area: Cancer

Solubility: 10 mM in DMSO

Target: FGFR

• SKU: MEXHY-P99384-10
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-P99384-10
• Green Labware: No
• Package Unit: 10 mg
• Quantity Unit: STK